Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75,482,273
-
Total 13F shares
-
17,679,705
-
Share change
-
+10,953,255
-
Total reported value
-
$36,895,000
-
Price per share
-
$2.08
-
Number of holders
-
38
-
Value change
-
+$23,156,863
-
Number of buys
-
26
-
Number of sells
-
8
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q4 2020
As of 31 Dec 2020,
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,679,705 shares.
The largest 10 holders included
Consonance Capital Management LP, Sio Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, Maven Securities LTD, VANGUARD GROUP INC, 683 Capital Management, LLC, BOXER CAPITAL, LLC, Altium Capital Management LP, BlackRock Inc., and Tri Locum Partners LP.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.